Posts

Carmell to merge with regenerative medicine company Axo...

Carmell Therapeutics has entered a definitive agreement and plan of merger with ...

Bristol Myers Squibb reports 6% drop in Q2 2023 revenues

Bristol Myers Squibb has reported revenues of $11.2bn in the second quarter of 2...

InSilicoTrials and Axoltis to develop drugs for neurolo...

InSilicoTrials has entered a partnership with Axoltis Pharma for the advancement...

Gilead gains EC approval for metastatic breast cancer d...

Gilead Sciences has received approval from EC for Trodelvy, for pre-treated HR-p...

How did hiring in the Indian pharma industry perform in...

The Indian pharma industry experienced a 23% drop in hiring activity in Q2 2023,...

NS Pharma scores breakthrough therapy status for DMD th...

NS Pharma’s candidate would be the first to target Duchenne Muscular Dystrophy (...

To detect breast cancer sooner, an MIT professor design...

New research describes a flexible ultrasound that can be worn in a bra and could...

STAT+: House GOP offers new plan to stem drug shortages...

House Republicans have drafted legislation to address cancer and other drug shor...

STAT+: AstraZeneca buys early-stage gene therapies from...

AstraZeneca has been trying to ratchet up its rare disease efforts, spending $39...

His book on the opioid crisis flopped in 2003. It now h...

"Until we understand how it happens, and how to stop it from happening, we're go...

STAT+: Pharmalittle: Pharma hopes reformulated drugs wi...

Drug companies believe injectable versions of some cancer drugs are likely to be...

STAT+: Biogen to acquire Reata Pharmaceuticals in $7 bi...

Biogen on Friday said it would acquire Reata Pharmaceuticals, the maker of an ap...

Opinion: Many immigrants are ineligible for important U...

Without state and federal action, immigrants will face unequal access to U.S. ma...

Opinion: Doctors in states that ban abortion can still ...

Refusing to provide abortion information in order to minimize legal risk violate...

STAT+: With profitability in sight, Talkspace is buddin...

With profitability in sight, Talkspace is budding into a digital health success ...

STAT+: Midwest health systems Fairview and Sanford call...

Resistance from the University of Minnesota, whose main teaching hospital in Min...